These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 1665907

  • 1. Aspartic acid 50 and tyrosine 108 are essential for receptor binding and cytotoxic activity of tumour necrosis factor beta (lymphotoxin).
    Goh CR, Loh CS, Porter AG.
    Protein Eng; 1991 Oct; 4(7):785-91. PubMed ID: 1665907
    [Abstract] [Full Text] [Related]

  • 2. Galloway Memorial Lecture. Protein engineering of tumor necrosis factor-beta and its applications in cancer, septicaemia and cachexia.
    Goh CR.
    Ann Acad Med Singap; 1993 Jul; 22(4):651-6. PubMed ID: 8257076
    [Abstract] [Full Text] [Related]

  • 3. Site-directed mutational analysis of human tumor necrosis factor-alpha receptor binding site and structure-functional relationship.
    Zhang XM, Weber I, Chen MJ.
    J Biol Chem; 1992 Nov 25; 267(33):24069-75. PubMed ID: 1331108
    [Abstract] [Full Text] [Related]

  • 4. The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding.
    Eck MJ, Sprang SR.
    J Biol Chem; 1989 Oct 15; 264(29):17595-605. PubMed ID: 2551905
    [Abstract] [Full Text] [Related]

  • 5. The structure of tumour necrosis factor--implications for biological function.
    Jones EY, Stuart DI, Walker NP.
    J Cell Sci Suppl; 1990 Oct 15; 13():11-8. PubMed ID: 1964681
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Woodchuck lymphotoxin-alpha, -beta and tumor necrosis factor genes: structure, characterization and biological activity.
    Li DH, Havell EA, Brown CL, Cullen JM.
    Gene; 2000 Jan 25; 242(1-2):295-305. PubMed ID: 10721723
    [Abstract] [Full Text] [Related]

  • 8. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation.
    Banner DW, D'Arcy A, Janes W, Gentz R, Schoenfeld HJ, Broger C, Loetscher H, Lesslauer W.
    Cell; 1993 May 07; 73(3):431-45. PubMed ID: 8387891
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of modification of all loop regions in the alpha- and beta-subunits of human choriogonadotropin on its signal transduction activity.
    Shao K, Purohit S, Bahl OP.
    Mol Cell Endocrinol; 1996 Sep 18; 122(2):173-82. PubMed ID: 8902847
    [Abstract] [Full Text] [Related]

  • 12. The structure of human lymphotoxin (tumor necrosis factor-beta) at 1.9-A resolution.
    Eck MJ, Ultsch M, Rinderknecht E, de Vos AM, Sprang SR.
    J Biol Chem; 1992 Feb 05; 267(4):2119-22. PubMed ID: 1733919
    [Abstract] [Full Text] [Related]

  • 13. Novel muteins of human tumor necrosis factor alpha.
    Ito R, Matsumoto H, Uchida K, Kubo T, Tsukii Y, Endo T, Kaji A.
    Biochim Biophys Acta; 1991 Apr 15; 1096(3):245-52. PubMed ID: 2018798
    [Abstract] [Full Text] [Related]

  • 14. Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface.
    Browning JL, Ngam-ek A, Lawton P, DeMarinis J, Tizard R, Chow EP, Hession C, O'Brine-Greco B, Foley SF, Ware CF.
    Cell; 1993 Mar 26; 72(6):847-56. PubMed ID: 7916655
    [Abstract] [Full Text] [Related]

  • 15. Human tumor necrosis factor mutants with preferential binding to and activity on either the R55 or R75 receptor.
    Van Ostade X, Vandenabeele P, Tavernier J, Fiers W.
    Eur J Biochem; 1994 Mar 15; 220(3):771-9. PubMed ID: 8143731
    [Abstract] [Full Text] [Related]

  • 16. Structural and functional domains in human tumour necrosis factors.
    Goh CR, Porter AG.
    Protein Eng; 1991 Apr 15; 4(4):385-9. PubMed ID: 1715560
    [Abstract] [Full Text] [Related]

  • 17. Construction and properties of fusion proteins between human interferon-gamma and human tumour necrosis factors alpha and beta.
    Korobko VG, Davydov IV, Shingarova LN, Filippov SA, Esipov DS, Dobrynin VN.
    Biomed Sci; 1991 Apr 15; 2(6):634-40. PubMed ID: 1668714
    [Abstract] [Full Text] [Related]

  • 18. Model complexes of tumor necrosis factor-alpha with receptors R1 and R2.
    Fu ZQ, Harrison RW, Reed C, Wu J, Xue YN, Chen MJ, Weber IT.
    Protein Eng; 1995 Dec 15; 8(12):1233-41. PubMed ID: 8869635
    [Abstract] [Full Text] [Related]

  • 19. Mutational analysis of structure--activity relationships in human tumor necrosis factor-alpha.
    Yamagishi J, Kawashima H, Matsuo N, Ohue M, Yamayoshi M, Fukui T, Kotani H, Furuta R, Nakano K, Yamada M.
    Protein Eng; 1990 Aug 15; 3(8):713-9. PubMed ID: 2217144
    [Abstract] [Full Text] [Related]

  • 20. Preparation and characterization of soluble recombinant heterotrimeric complexes of human lymphotoxins alpha and beta.
    Browning JL, Miatkowski K, Griffiths DA, Bourdon PR, Hession C, Ambrose CM, Meier W.
    J Biol Chem; 1996 Apr 12; 271(15):8618-26. PubMed ID: 8621492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.